Catheter ablation therapy has become a key intervention in treatment of recurrent Ventricular Tachycardia (VT) 
Introduction
Ventricular tachycardia (VT) occurs in patients with structural heart disease and can be associated with an increased risk of sudden death [1] . Conventional techniques such as Implantable Cardioverter-Defibrillators (ICDs) are effective treatments for cardiomyopathy, and have been shown to reduce cardiovascular death and total mortality in patients with reduced ejection fraction after Myocardial Infarction [2] . However, ICDs play a limited role in that they only terminate VTs, not prevent them. Furthermore, ICD shocks can be painful for the patient, they increase mortality, and worsen quality of life [3] .
Catheter ablation therapy has progressed significantly over the past few years and is now an important option to control recurrent VTs [1] . Catheter ablation can prevent recurrent VT without the need for long-term antiarrhythmic therapy, and reduce the need for ICD shocks. Current ablation techniques focus on isolating scar tissue by targeting reentry circuit isthmuses and their exits [4] . To accomplish this, the area of the scar must first be defined with the assistance of an electroanatomical system. Substrate mapping can be performed using voltage, pace mapping, and registration of electrogram features suggestive of abnormal myocardium. Though substrate mapping alone can be used to guide the ablation, combining it with short episodes of activation, and entrainment mapping to isolate fractionation increases the likelihood of successful ablation [4] . However, current fractionation mapping methods used to isolate the ablation targets in VT patients are done manually, and are therefore time consuming. They also have a limited success rate, with an approximately 50% recurrence rate within 2 years [5] .
We propose an automated fractionation detection method for VT patients which can potentially increase the accuracy and success rate of the ablation therapy. Performance is evaluated by comparing the results between the test (patients with VT) and control cohort (normal heart and absence of VT).
Materials
Intracardiac bipolar electrogram (sampling rate 2034.5Hz) segments were recorded using the impedance based 3D navigation system (EnSite™ Velocity™; St. Jude Medical, MN 
Methods
Ventricular effective refractory period (VERP) was determined at the right ventricular apex (RVA) using a drive train of 600ms (S1) and decreasing extrastimuli (S2) to non-capture. Signals were recorded from the left ventricle (LV) of patients using the roving catheter positioned at various locations guided by the mapping system to ensure complete endocardial coverage. Data were collected during pacing trains from the RVA of 600/(VERP+150), 600/(VERP+100) and 600/(VERP+50) for each data collection site. The S1 consisted of six beats based on the physiological constraints of the patient and technician oversight. An example of a standard pacing train can be seen in Figure 1 . The first three pacing spikes are S1 interval and the last pacing spike is the extrastumli (S2).
The data analysis for fractionation detection can be divided into three main processing steps: preprocessing, ventricular peak detection, and feature extraction. Preprocessing consisted of a Discrete Wavelet Transformation based approach [6] to remove baseline wander and low-frequency noise; a Butterworth low pass filter (300Hz) to remove high frequency disturbances and lastly, Teagers -Kaiser Energy operator to simplify peak detection ( Figure 2 ). All data analysis was done in Matlab (Mathworks Inc).
Teager -Kaiser Energy Operator
Teager-Kaiser Energy operator (TK) is a nonlinear quadratic operator proposed by Teager [7] to measure the real physical energy of a system (En):
where x(n) is a discrete time signal and n is the discrete time index. This operator is capable of tracking instantaneously-varying special patterns making it ideal for isolating and emphasizing peaks in intracardiac recordings.
Peak detection
Peaks isolated were filtered if their amplitude was too low, or if they were of a distance of less than 250ms with respect to their neighbour (VERP is rarely less than 200ms [8] ). Responses on the surface ECG were monitored to isolate and discard possible anomalies in the data resulting in a non-capture; such as sinus beats and ectopy as shown in Figure 3 . 
Feature extraction
Fractionation in our study was defined by three features: latency (conduction time (CT) normalized to the drive train), local bipolar electrogram (EGM) duration, and number of deflections within the EGM duration window. CT refers to the time between a pacing artifact and the start of a local EGM activation at the target location, this is normalized by subtracting the CT during the drive train at that location during S2 to provide a measure of latency defined at the delay between delivery of the pacing stimulus and onset of local potential. EGM duration refers to the duration of the local activation from start to end; and deflections is the total number of peaks found in the activation. An example of all three can be found in Figure  4 . After pre-processing, these three features were extracted from each recording. CT was identified by linking pacing spikes in the pacing catheter, to response spikes in the roving catheter. Response spikes were identified by isolating the largest signal peak in the roving catheter (point 'B' in Figure 5 ) that occurred after a pace (point 'A' in Figure 5) , and before the next pace in the train (point 'C' in Figure 5 ).
Results and discussion
The three previously defined features were extracted from all test and control patients. An average of 174±113 locations per test patient and 89±29 per control patient were obtained. The difference explained by the much larger size of the test ventricles. Figure 6 shows the distribution of data from test and control. The majority of data from both groups lies within the normal range yet, as anticipated, the test patients demonstrate a significantly greater proportion of data outside the normal range and this is exposed with decreasing coupling interval of S2.
Control patients were employed to determine normal responses and data spread, this derivation cohort provide the normal values observed in Figure 6 . EGM duration did increase slightly in controls but here was no change in fractionation and only a trend toward increased latency at this coupling interval. This is consistent with prior physiological observation [9] where significant changes only occur at much tighter coupling intervals. However there was a significant change in latency observed in test subjects as expected. There was also a significant difference in latency between both groups at each S2. These data demonstrate the practical utility of the automated process to geographically isolate areas with abnormal responses from areas falling within the normal range. Table 1 shows the percentage of data that were retained in the test dataset after removal of normal range data. The results show that latency as a function of abnormal behaviour appears to change little with decreasing S2; however it is unclear if individual data points remain stable or if there is change in geographical distribution of latency, this requires further study. More interesting is the response of the EGM characteristics with a reduction in abnormal classification with decreasing S2. This suggests much of this abnormal tissue cannot sustain the faster conduction and physiologically 'block'. This is an important observation as such sites may not be responsible for faster VT and may be targeted Figure 6 . A comparison between Test and Control patients for the features EGM duration, latency and deflections from left to right respectively; for all three pacing intervals. Solid horizontal lines represents the median value for the control patients for specified dataset. as a secondary endpoint. Such physiologic correlations may allow operators to discriminate abnormal substrate much faster and avoid a large amount of possible unnecessary ablation in this cohort.
In this paper, we showed that automated detection of fractionation metrics within VT patients is possible, and that the data obtained is correlative with arrhythmia. Furthermore, we wanted to see if PEFA would be effective at isolating arrhythmogenic tissue for better targeted ablation. The sites defined as abnormal using our controls might be effective in allowing us to do so and can be readily applied to conventional mapping systems.
